Alfred Sandrock, Head of Research & Development at Biogen, holds 430.93K shares in Voyager Therapeutics (Ticker: VYGR), holds 10.17K shares in Biogen (Ticker: BIIB), holds 0.00 shares in Neurocrine (Ticker: NBIX). Most recently, Alfred Sandrock Sold ― shares of Voyager Therapeutics on Apr 04, 2025 for an estimated value of 37.34K.
What is the percentage of profitable transactions made by Alfred Sandrock?
The percentage of profitable transactions made by Alfred Sandrock is 80%.
What is the average return per transaction made by Alfred Sandrock?
The average return per transaction made by Alfred Sandrock is 24.50%.
What stocks does Alfred Sandrock hold?
Alfred Sandrock holds: BIIB, VYGR, NBIX stocks.
What was Alfred Sandrock’s latest transaction?
Alfred Sandrock latest transaction was an Informative Sell of $37.34K.
What was Alfred Sandrock's most profitable transaction?
Alfred Sandrock’s most profitable transaction was an Informative Sell of VYGR stock on April 3, 2024. The return on the trade was 66.70%.
What is Alfred Sandrock's role in Biogen?
Alfred Sandrock's role in Biogen is Head of Research & Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.